ALB and lung cancer: Additionally, PFT-HSA-TFT-Cy7 reduced the fluorescent AGEs in the lung cancer animal model by 8.7% and 21.05% at 1 μM and 3 μM, respectively, while PFT-Hcy-HSA-Cy7 showed 6.57% and 19.29% inhibition of fluorescent AGEs in the same model.